These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39074404)

  • 1. Tobacco use increases lesion burden in familial cerebral cavernous malformation syndrome.
    Flemming KD; Wicker K; Lanzino G
    J Clin Neurosci; 2024 Sep; 127():110767. PubMed ID: 39074404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.
    Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H;
    J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of familial and sporadic pediatric cerebral cavernous malformations and outcomes.
    Jaman E; Abdallah HM; Zhang X; Greene S
    J Neurosurg Pediatr; 2023 Oct; 32(4):506-513. PubMed ID: 37503918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.
    Choquet H; Nelson J; Pawlikowska L; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H
    Cerebrovasc Dis; 2014; 37(1):57-63. PubMed ID: 24401931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non-familial disease.
    Santos AN; Rauschenbach L; Saban D; Chen B; Darkwah Oppong M; Herten A; Gull HH; Rieß C; Deuschl C; Schmidt B; Jabbarli R; Wrede KH; Zhu Y; Frank B; Sure U; Dammann P
    Eur J Neurol; 2022 May; 29(5):1427-1434. PubMed ID: 35060255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.
    Choquet H; Trapani E; Goitre L; Trabalzini L; Akers A; Fontanella M; Hart BL; Morrison LA; Pawlikowska L; Kim H; Retta SF
    Free Radic Biol Med; 2016 Mar; 92():100-109. PubMed ID: 26795600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliable? The Value of Early Postoperative Magnetic Resonance Imaging after Cerebral Cavernous Malformation Surgery.
    Chen B; Göricke S; Wrede K; Jabbarli R; Wälchli T; Jägersberg M; Sure U; Dammann P
    World Neurosurg; 2017 Jul; 103():138-144. PubMed ID: 28391022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.
    Choquet H; Pawlikowska L; Nelson J; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H;
    Cerebrovasc Dis; 2014; 38(6):433-40. PubMed ID: 25472749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form.
    Sparacia G; Speciale C; Banco A; Bencivinni F; Midiri M
    Neuroradiol J; 2016 Oct; 29(5):326-35. PubMed ID: 27549150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rupture risk analysis of cerebral cavernous malformation associated with developmental venous anomaly using susceptibility-weighted imaging.
    Zhang S; Ma L; Wu C; Wu J; Cao Y; Wang S; Zhao J
    Neuroradiology; 2020 Jan; 62(1):39-47. PubMed ID: 31482190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.
    Dammann P; Wrede K; Zhu Y; Matsushige T; Maderwald S; Umutlu L; Quick HH; Hehr U; Rath M; Ladd ME; Felbor U; Sure U
    J Neurosurg; 2017 Feb; 126(2):570-577. PubMed ID: 27153162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the association of common genetic variants in EPHB4 and RASA1 with phenotype severity in familial cerebral cavernous malformation.
    Choksi F; Weinsheimer S; Nelson J; Pawlikowska L; Fox CK; Zafar A; Mabray MC; Zabramski J; Akers A; Hart BL; Morrison L; McCulloch CE; Kim H
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1794. PubMed ID: 34491620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous findings of familial cerebral cavernous malformation syndrome due to the common Hispanic mutation.
    Manole AK; Forrester VJ; Zlotoff BJ; Hart BL; Morrison LA
    Am J Med Genet A; 2020 May; 182(5):1066-1072. PubMed ID: 32100472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Cerebral Cavernous Malformations Are Associated with Adrenal Calcifications on CT Scans: An Imaging Biomarker for a Hereditary Cerebrovascular Condition.
    Strickland CD; Eberhardt SC; Bartlett MR; Nelson J; Kim H; Morrison LA; Hart BL
    Radiology; 2017 Aug; 284(2):443-450. PubMed ID: 28318403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertebral Intraosseous Vascular Malformations in a Familial Cerebral Cavernous Malformation Population: Prevalence, Histologic Features, and Associations With CNS Disease.
    Tandberg SR; Bocklage T; Bartlett MR; Morrison LA; Nelson J; Hart BL
    AJR Am J Roentgenol; 2020 Feb; 214(2):428-436. PubMed ID: 31825263
    [No Abstract]   [Full Text] [Related]  

  • 16. Focal epilepsy caused by single cerebral cavernous malformation (CCM) is associated with regional and global resting state functional connectivity (FC) disruption.
    D'Cruz J; Hefner M; Ledbetter C; Frilot C; Howard B; Zhu P; Riel-Romero R; Notarianni C; Toledo EG; Nanda A; Sun H
    Neuroimage Clin; 2019; 24():102072. PubMed ID: 31734529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and Morbidity of Magnetic Resonance Imaging-Guided Stereotactic Laser Ablation of Deep Cerebral Cavernous Malformations: A Report of 4 Cases.
    Malcolm JG; Douglas JM; Greven A; Rich C; Dawoud RA; Hu R; Reisner A; Barrow DL; Gross RE; Willie JT
    Neurosurgery; 2021 Sep; 89(4):635-644. PubMed ID: 34270738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging.
    Flemming KD; Graff-Radford J; Aakre J; Kantarci K; Lanzino G; Brown RD; Mielke MM; Roberts RO; Kremers W; Knopman DS; Petersen RC; Jack CR
    JAMA Neurol; 2017 Jul; 74(7):801-805. PubMed ID: 28492932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype.
    Petersen TA; Morrison LA; Schrader RM; Hart BL
    AJNR Am J Neuroradiol; 2010 Feb; 31(2):377-82. PubMed ID: 19833796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel CCM1 (KRIT1) Mutation Detection in Brazilian Familial Cerebral Cavernous Malformation: Different Genetic Variants in Inflammation, Oxidative Stress, and Drug Metabolism Genes Affect Disease Aggressiveness.
    Fontes-Dantas FL; da Fontoura Galvão G; Veloso da Silva E; Alves-Leon S; Cecília da Silva Rêgo C; Garcia DG; Marques SA; Blanco Martinez AM; Reis da Silva M; Marcondes de Souza J
    World Neurosurg; 2020 Jun; 138():535-540.e8. PubMed ID: 32113992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.